PBM research for lymphatic conditions focuses mainly on breast-cancer-related lymphedema. Evidence suggests possible adjunctive benefits, but protocols and certainty remain limited. The article explains mechanisms, dosing, safety risks, and device documentation while rejecting universal home-treatment or “lymphatic detox” claims.